ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102817 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102817; 2) Community: the network communities that were significantly associated with the response to NSC 102817; 3) Molecule: the relationships between components within communities and NSC 102817; 4) MDR: the compounds that were significantly associated with the NSC 102817.

NSC Compound Enrichment Correlation
NSC 208734 ACLACINOMYCIN A 0.0421163101172308 0.22355155
NSC 31768 Null 0.0421163101172308 0.16075799
NSC 349447 Indolo[2,1-b]quinazoline-6,12-dione (8CI9CI) 0.0421163101172308 0.24708712
NSC 373355 Saframycin R 0.0421163101172308 0.50888714
NSC 381811 Poly(oxy-1,2-ethanediyl), .alpha.-methyl-.omega.-[[3- (5-fluoro-1,2,3,4-tetrahydro-2,4-dioxo-1-pyrimidinyl)- 1-oxopropyl]oxy]- 0.0421163101172308 0.033408378
NSC 602313 Null 0.0421163101172308 0.19666411
NSC 609815 2-Benzoylaminobenzamide, N-thiazol-2-yl- 0.0421163101172308 0.34124956
NSC 610456 Camptothecin Derivative 0.0421163101172308 -0.0016910032
NSC 612223 Null 0.0421163101172308 0.30668077
NSC 623128 14-FLUORO-4-DEMETHOXYDAUNORUBICIN 0.0421163101172308 0.14474328
Total:136  Current:124    [First] [Prev] [Next] [Last]